Seattle, WA, United States of America

Michael David Feese

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2007-2025

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Michael David Feese

Introduction:

Michael David Feese, a prolific inventor based in Seattle, WA, is known for his groundbreaking work in developing compounds to inhibit the replication of influenza and hepatitis C viruses. With a total of 5 patents to his name, Feese's contributions to the field of antiviral medications have been significant and impactful.

Latest Patents:

Feese's latest patents include innovative technologies such as Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication. These compounds have shown promise in inhibiting the replication of influenza viruses in biological samples, reducing viral loads, and treating influenza in patients. Additionally, his work on Inhibitors of Hepatitis C virus polymerase has led to the development of compounds that are effective in combating HCV infections.

Career Highlights:

During his career, Michael David Feese has been associated with notable companies such as Cocrystal Pharma, Inc. His expertise and dedication to antiviral research have positioned him as a key figure in the industry. Feese's commitment to developing novel solutions for viral infections has been instrumental in advancing the field of antiviral therapeutics.

Collaborations:

Feese has collaborated with esteemed professionals in the field, including coworkers Irina C Jacobson and Sam S K Lee. Their combined efforts have resulted in the successful development and patenting of innovative compounds that hold great promise in the fight against influenza and hepatitis C infections.

Conclusion:

Michael David Feese's relentless pursuit of innovation in antiviral research has established him as a trailblazer in the field. His patents stand as a testament to his dedication to developing effective treatments for viral infections, and his collaborations underscore the value of teamwork in advancing scientific discoveries. As he continues to drive progress in the field of antiviral medications, Michael David Feese remains a formidable force in the fight against infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…